GAMC
PROK icon

Garner Asset Management Corp’s ProKidney PROK Stock Holding History

Garner Asset Management Corp’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-800
Closed -$1.79K – 333
2025
Q4 		$1.79K Buy
+800
New +$2.1K ﹤0.01% 394

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Garner Asset Management Corp's PROK Position: Q1 2026 in Review

Garner Asset Management Corp sold out of ProKidney (PROK) in Q1 2026, closing a stake of 800 shares — an estimated $1.79K sold.

Garner Asset Management Corp first reported a position in PROK in Q4 2025 and held it in 1 quarter. The position peaked at $1.79K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Garner Asset Management Corp reported no remaining ProKidney position as of Q1 2026 after selling out during the quarter.
  • Garner Asset Management Corp sold 800 ProKidney shares in Q1 2026, an estimated $1.79K.
  • Garner Asset Management Corp first reported a position in ProKidney in Q4 2025 and held it in 1 quarter.
  • Garner Asset Management Corp's ProKidney position peaked at $1.79K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.